BeOne Medicines
ONC
#769
Rank
โ‚ฌ27.73 B
Marketcap
267,34ย โ‚ฌ
Share price
0.20%
Change (1 day)
25.93%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): 4,12ย โ‚ฌ

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is 4,14ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 2,35ย โ‚ฌ an increase over its 2024 EPS that were of -5,38ย โ‚ฌ.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)4,12ย โ‚ฌ75.11%
20252,35ย โ‚ฌ-143.75%
2024-5,38ย โ‚ฌ
2022-16,80ย โ‚ฌ28.21%
2021-13,11ย โ‚ฌ-19.96%
2020-16,38ย โ‚ฌ20.81%
2019-13,55ย โ‚ฌ31.52%
2018-10,31ย โ‚ฌ417.57%
2017-1,99ย โ‚ฌ-37.16%
2016-3,17ย โ‚ฌ158.95%
2015-1,22ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-0,21ย โ‚ฌ-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-0,82ย โ‚ฌ-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA